Does Comorbidity Increase the Risk of Dengue Hemorrhagic Fever and Dengue Shock Syndrome?

Table 1

Comorbidities in dengue hemorrhagic fever cases in comparison to control population.

Characteristics	Cases (𝑛=132)		Controls (𝑛=249)		Total (𝑛=381)		𝜒^2	𝑃-value
	𝑁	%	𝑁	%	𝑁	%
Age (years)
<20	03	2.3	06	2.4	09	2.4	7.22	0.06
20–39	35	26.5	49	19.7	84	22.0
40–59	68	51.5	114	45.8	182	47.8
60+	26	19.7	80	32.1	106	27.8
Gender
Male	71	53.8	158	63.5	229	60.1	3.36	0.06
Female	61	46.2	91	36.5	152	39.9
Diabetes mellitus
Yes	57	43.2	104	41.8	161	42.3	0.07	0.79
No	75	56.8	145	58.2	220	57.7
Hypertension
Yes	67	50.8	135	54.2	202	53.0	0.41	0.52
No	65	49.2	114	45.8	179	47.0
Ischaemic heart disease
Yes	26	19.7	44	17.7	70	18.4	0.23	0.62
No	106	80.3	205	82.3	311	81.6
Bronchial asthma
Yes	14	10.6	23	9.2	37	9.7	0.18	0.66
No	118	89.4	226	90.8	344	90.3
Chronic liver disease
Yes	12	9.1	27	10.8	39	10.2	0.28	0.59
No	120	90.9	222	89.2	342	89.8
Pulmonary tuberculosis
Yes	10	7.6	13	5.2	23	6.0	0.84	0.35
No	122	92.4	236	94.8	358	94.0

⊢Column percentages presented.